Crucell Presents Update on Product Development Programs at Analyst Meeting
16. November 2004 08:52 ET
|
Crucell N.V.
LEIDEN, Netherlands, Nov. 16, 2004 (PRIMEZONE) -- Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) presented a comprehensive update on the Company's in-house and partnered product development programs...
Crucell Signs Agreement with IAVI to Develop AdVac(R) Vector for AIDS Vaccine Program
12. November 2004 02:06 ET
|
Crucell N.V.
LEIDEN, The Netherlands, Nov. 12, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and the International AIDS Vaccine Initiative (IAVI) announced today that...
Crucell to Produce West Nile Virus Vaccine for Use in Human Clinical Trials at Netherlands Vaccine Institute
10. November 2004 10:53 ET
|
Crucell N.V.
LEIDEN, Netherlands, Nov. 10, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and the Netherlands Vaccine Institute (NVI) announced today that they have...
Crucell N.V.: Wyeth Selects Novel Drug Targets in Osteoporosis Collaboration With Galapagos
09. November 2004 02:08 ET
|
Crucell N.V.
LEIDEN, The Netherlands and MECHELEN, Belgium, Nov. 9, 2004 (PRIMEZONE) -- Galapagos Genomics announced today that it has reached a research milestone in its osteoporosis discovery program with Wyeth...
Crucell to Webcast Analyst Day on November 16, 2004
05. November 2004 11:38 ET
|
Crucell N.V.
LEIDEN, Netherlands, Nov. 05, 2004 (PRIMEZONE) -- Crucell N.V. (Euronext, Nasdaq:CRXL), invites investors, the media and the general public to view a live video webcast of its Analyst Day Meeting at...
Crucell to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference, October 27
20. Oktober 2004 08:14 ET
|
Crucell N.V.
LEIDEN, Netherlands, Oct. 20, 2004 (PRIMEZONE) -- Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) has announced its Chief Financial Officer, Leonard Kruimer, will present at the Rodman & Renshaw...
Crucell and Merial Announce Commercial License Agreement for PER.C6 Technology for Foot-and-Mouth Disease Vaccines
18. Oktober 2004 02:08 ET
|
Crucell N.V.
LEIDEN, Netherlands and DULUTH, Ga., Oct. 18, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and Merial, a world-leading animal health company, today...
Crucell Reports Third Quarter 2004 Results
12. Oktober 2004 08:43 ET
|
Crucell N.V.
LEIDEN, The Netherlands, Oct. 12, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) today announced its financial results for the third quarter of 2004. Crucell...
Crucell Initiates Legal Proceedings Against CEVEC Over PER.C6 Patent Infringement
07. Oktober 2004 02:07 ET
|
Crucell N.V.
LEIDEN, The Netherlands, Oct. 7, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has initiated legal proceedings in the District...
Crucell Receives Two European Patents Covering its PER.C6 and AdVac Technology
06. Oktober 2004 02:11 ET
|
Crucell N.V.
LEIDEN, The Netherlands, Oct. 6, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has been granted two patents by the European patent...